phosphatase/neoplasms

This application incorporates a 502 KB text file named "seqlst00631" created Jul. 22, 2010, which is the sequence listing for this application. TECHNICAL FIELD OF THE INVENTION This invention is related to the area of cancer. In particular, it relates to diagnosis, prognosis, treatment, drug

TECHNICAL FIELD OF THE INVENTION This invention is related to the area of cancer. In particular, it relates to diagnosis, prognosis, treatment, drug discovery, target discovery, clinical testing for cancer. BACKGROUND OF THE INVENTION Phosphorylation of tyrosine residues is a central feature of most

BACKGROUND OF THE INVENTION Protein tyrosyl phosphorylation is an important cellular regulatory mechanism. Much work has implicated protein tyrosine kinases (PTKs) in the control of cell proliferation and differentiation. Many PTKs, when mutated and/or captured by retroviruses, can promote

FIELD OF THE INVENTION This invention relates to the use of human alkaline phosphatase, such as placental alkaline phosphatase or transferrin alone or alkaline phosphatase in combination with transferrin, and, optionally, .alpha..sub.1-antitrypsin to prevent or reduce the growth of skin cancer in

FIELD OF USE The present invention relates to the use of proteins which are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor treatment therapies. Specifically, the present invention relates to the use of

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Sep. 18, 2010, is named 26228PCT.txt and is 100,737 bytes in size. FIELD OF THE

FIELD The disclosure provides methods for characterizing a prostate cancer sample by detecting changes in expression of ERG and/or PTEN which are shown herein to be correlated with prostate cancer capsular penetration, biochemical recurrence, and more aggressive forms of prostate cancer. Also

FIELD The disclosure provides methods for characterizing a prostate cancer sample by detecting changes in expression of ERG and/or PTEN which are shown herein to be correlated with prostate cancer capsular penetration, biochemical recurrence, and more aggressive forms of prostate cancer. Also

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention provides maleiimide compounds and pharmaceutical compositions comprising same. The present invention further provides methods of regulating protein phosphorylation and dephosphorylation by phosphatases inhibition and methods

FIELD OF THE INVENTION This invention relates to the fields of prostate cancer diagnosis and treatment. BACKGROUND OF THE INVENTION Various scientific and scholarly articles are referred to in brackets throughout the specification. These articles are incorporated by reference herein to describe the

FIELD OF THE INVENTION The present invention relates to methods for treating cancer. BACKGROUND OF THE INVENTION Each year 1.1 million new cases of breast cancer occur among women worldwide and 400,000 women will die from this disease (www.uicc.org, www.who.int). Although progress has been made in

INCORPORATION OF SEQUENCE LISTING The contents of the text file named "28856-502C02US_ST25.txt", which was created on Sep. 22, 2010 and is 3 KB in size, are hereby incorporated by reference in their entirety. BACKGROUND OF THE INVENTION Protein kinases are a large class of enzymes which catalyze the

BACKGROUND OF THE INVENTION Protein kinases are a large class of enzymes which catalyze the transfer of the .gamma.-phosphate from ATP to the hydroxyl group on the side chain of Ser/Thr or Tyr in proteins and peptides and are intimately involved in the control of various important cell functions,

FIELD OF THE INVENTION The present invention relates to methods of diagnosing and treating certain types of cancer and pre-cancerous conditions, including those deriving from hematopoietic cells such as myeloid cells and lymphoid cells. In particular, the invention pertains to diagnostic and

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the field of cancer diagnostics and therapeutics. In particular it relates to a gene which appears to be significantly associated with the progression of cancer to more advanced stages, including metastasis. 2. Background